BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 28618167)

  • 1. Neuropilin-1 regulated by miR-320 contributes to the growth and metastasis of cholangiocarcinoma cells.
    Zhu H; Jiang X; Zhou X; Dong X; Xie K; Yang C; Jiang H; Sun X; Lu J
    Liver Int; 2018 Jan; 38(1):125-135. PubMed ID: 28618167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropilin-1 is associated with clinicopathology of gastric cancer and contributes to cell proliferation and migration as multifunctional co-receptors.
    Li L; Jiang X; Zhang Q; Dong X; Gao Y; He Y; Qiao H; Xie F; Xie X; Sun X
    J Exp Clin Cancer Res; 2016 Jan; 35():16. PubMed ID: 26795388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
    Zhu H; Mi Y; Jiang X; Zhou X; Li R; Wei Z; Jiang H; Lu J; Sun X
    J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1.
    Chang W; Wang Y; Li W; Shi L; Geng Z
    J Cell Mol Med; 2019 Aug; 23(8):4945-4954. PubMed ID: 31199052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
    Liu B; Hu Y; Qin L; Peng XB; Huang YX
    Dig Liver Dis; 2019 Mar; 51(3):397-411. PubMed ID: 30314946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The miR-141/neuropilin-1 axis is associated with the clinicopathology and contributes to the growth and metastasis of pancreatic cancer.
    Ma L; Zhai B; Zhu H; Li W; Jiang W; Lei L; Zhang S; Qiao H; Jiang X; Sun X
    Cancer Cell Int; 2019; 19():248. PubMed ID: 31572065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway.
    Leng K; Xu Y; Kang P; Qin W; Cai H; Wang H; Ji D; Jiang X; Li J; Li Z; Huang L; Zhong X; Sun X; Wang Z; Cui Y
    Cell Death Dis; 2019 Mar; 10(4):262. PubMed ID: 30886152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA TTN-AS1 promotes the progression of cholangiocarcinoma via the miR-320a/neuropilin-1 axis.
    Zhu H; Zhai B; He C; Li Z; Gao H; Niu Z; Jiang X; Lu J; Sun X
    Cell Death Dis; 2020 Aug; 11(8):637. PubMed ID: 32801339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-26a induced the suppression of tumor growth of cholangiocarcinoma via KRT19 approach.
    Wang P; Lv L
    Oncotarget; 2016 Dec; 7(49):81367-81376. PubMed ID: 27833076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
    Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
    BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-21 regulates biological behavior by inducing EMT in human cholangiocarcinoma.
    Liu Z; Jin ZY; Liu CH; Xie F; Lin XS; Huang Q
    Int J Clin Exp Pathol; 2015; 8(5):4684-94. PubMed ID: 26191158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of circular RNA circ_0005230 facilitates cell growth and metastasis via sponging miR-1238 and miR-1299 in cholangiocarcinoma.
    Xu Y; Yao Y; Liu Y; Wang Z; Hu Z; Su Z; Li C; Wang H; Jiang X; Kang P; Sun D; Zhong X; Cui Y
    Aging (Albany NY); 2019 Apr; 11(7):1907-1917. PubMed ID: 30946694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated microRNA-194 impairs stemness of cholangiocarcinoma cells through the Rho pathway via inhibition of ECT2.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    J Cell Biochem; 2020 Oct; 121(10):4239-4250. PubMed ID: 31960990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of ZFAS1 indicates dismal prognosis for cholangiocarcinoma and promotes proliferation and metastasis by modulating USF1 via miR-296-5p.
    Li Z; Jiang X; Huang L; Li J; Ji D; Xu Y; Leng K; Cui Y
    J Cell Mol Med; 2019 Dec; 23(12):8258-8268. PubMed ID: 31565837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNA-124-3p/neuropilin-1(NRP-1) axis plays an important role in mediating glioblastoma growth and angiogenesis.
    Zhang G; Chen L; Khan AA; Li B; Gu B; Lin F; Su X; Yan J
    Int J Cancer; 2018 Aug; 143(3):635-644. PubMed ID: 29457830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
    Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
    Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SP1-induced HOXD-AS1 promotes malignant progression of cholangiocarcinoma by regulating miR-520c-3p/MYCN.
    Li J; Jiang X; Li Z; Huang L; Ji D; Yu L; Zhou Y; Cui Y
    Aging (Albany NY); 2020 Aug; 12(16):16304-16325. PubMed ID: 32857725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The miR-124-3p/Neuropilin-1 Axis Contributes to the Proliferation and Metastasis of Triple-Negative Breast Cancer Cells and Co-Activates the TGF-β Pathway.
    Zhang J; Zhang X; Li Z; Wang Q; Shi Y; Jiang X; Sun X
    Front Oncol; 2021; 11():654672. PubMed ID: 33912463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.
    Peng F; Jiang J; Yu Y; Tian R; Guo X; Li X; Shen M; Xu M; Zhu F; Shi C; Hu J; Wang M; Qin R
    Br J Cancer; 2013 Dec; 109(12):3092-104. PubMed ID: 24169343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of neuropilin-1 enhances the therapeutic effects of lenvatinib in suppressing cholangiocarcinoma cells via the c-Met pathway.
    Zheng C; Wang H; Zhao S; Ma C; Gao H; Yang F; Zhou X; Lu J; Zhang C; Zhu H
    Eur J Pharmacol; 2022 Nov; 935():175290. PubMed ID: 36206942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.